Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.04654 | 66 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.05075 | 67 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.93022 | 65 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.31572 | 69 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.02979 | 67 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.05889 | 66 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.77699 | 62 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.12691 | 68 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.03409 | 67 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.14319 | 68 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.19008 | 68 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.05161 | 67 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.03996 | 67 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.03685 | 67 |